Article Sidebar
Views PDF: 828
DISTRIBUTION OF METHICILLIN-RESISTANT S. AUREUS (MRSA) AND MINIMUM INHIBITORY CONCENTRATION OF VANCOMYCIN TO MRSA ISOLATED IN THAI NGUYEN CENTRAL HOSPITAL
Main Article Content
Abstract
Vancomycin, the first line antibiotic for methicillin-resistant Staphylococcus aureus (MRSA). However, an increasing number of MRSA isolates with high MICs, within the susceptible range (vancomycin MIC creep), are being reported worldwide. This study aims to determine the minimum inhibitory concentration (MIC) of vancomycin for MRSA at Thainguyen Central Hospital. Methods: Cross-sectional descriptive research. Collection of 140 MRSAs isolated infection at Thainguyen Central Hospital from 01/2020 to 12/2020. Determination of MRSA by using the Kirby-Bauer disk-diffusion technique. MIC of vancomycin to confirmed MRSA strains were determined by Etest method. Results: A total of 140 S. aureus isolates from different specimens in this study; MRSA rate is 61,43% (86 strains), Minimum inhibitory concentrations of vancomycin to the strains of MRSA ranged from 0.5 μg/ml to 2 μg/ml. The number of strains with MIC of 1.5 μg/ml -2 μg/ml were 44 (51,14%). Most of the MRSA strains were resistant against multiple classes of commonly used antibiotics.
Article Details
Keywords
S. aureus, MRSA, vancomycin
References
Số 2), tr. 485-490.
2. Phùng Thị Thường, Đặng Văn Xuyên, Đoàn Mai Phương, Nguyễn Thái Sơn (2019), “Nghiên cứu nồng độ ức chế tối thiểu của vancomycin với các chủng Staphylococcus aureus phân lập từ bệnh nhân nhiễm khuẩn huyết tại Bệnh viện Bạch Mai”, Tạp chí Nghiên cứu và thực hành nhi khoa, Số 2 (4-2019), tr.56-63
3. Chia-Ning Chang, Wen-Tsung Lo, Ming-Chin Chan, et al (2017), “An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan”, Journal of Microbiology, Immunology and Infection, 50 (3), pp. 362-369.
4. Clinical and Laboratory Standards Institute (2016), "Performance Standards for Antimicrobial Susceptibility Testing", 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Moses et al. (2020), “Minimum Inhibitory Concentrations of Vancomycin and Daptomycin Against Methicillin-resistant Staphylococcus Aureus Isolated from Various Clinical Specimens: A Study from South India”, Cureus 12(1): e6749. DOI 10.7759/cureus.6749
6. Raghabendra Adhikari, Narayan Dutt Pant, Sanjeev Neupane, et al (2017), “Detection of Methicillin Resistant Staphylococcus aureus and Determination of Minimum Inhibitory Concentration of Vancomycin for Staphylococcus aureus Isolated from Pus/Wound Swab Samples of the Patients Attending a Tertiary Care Hospital in Kathmandu, Nepal”, Canadian Journal of Infectious Diseases and Medical Microbiology, Article ID 2191532, doi.org/10.1155/2017/2191532
7. van Hal S.J., Lodise T.P., Paterson D.L. (2012), “The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis”, Clin. Infect. Dis. 54(6), 755–771.
8. World Health Organization (2017), "Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics".